Corvus Pharmaceuticals (CRVS) Treasury Shares (2015 - 2024)
Corvus Pharmaceuticals (CRVS) recorded quarterly Treasury Shares of $400000.0 in Q3 2024, little changed quarter-over-quarter from $400000.0 in Q2 2024.
Corvus Pharmaceuticals (CRVS) Treasury Shares (2015 - 2024) Analysis & Trends
Corvus Pharmaceuticals' Treasury Shares history runs 7 years deep, the most recent figure standing at $400000.0 for Q3 2024.
- In Q3 2024, Treasury Shares changed N/A year-over-year to $400000.0; the TTM figure through Sep 2024 stood at $400000.0 (changed N/A YoY), while the FY2023 annual figure was $400000.0, changed N/A from the prior year.
- Treasury Shares was $400000.0 for Q3 2024 at Corvus Pharmaceuticals, roughly flat from $400000.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $400000.0 in Q4 2023 to a low of $400000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Corvus Pharmaceuticals | 1.00 Bn | 766.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 400,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Dec 31, 2023 | 400,000.00 |
| Dec 31, 2023 | 400,000.00 |
| Jun 30, 2019 | 12,384.00 |
| Jun 30, 2019 | 12,384.00 |
| Mar 31, 2019 | 27,073.00 |
| Mar 31, 2019 | 27,073.00 |
| Dec 31, 2018 | 43,076.00 |
| Dec 31, 2018 | 43,076.00 |
| Sep 30, 2018 | 99,831.00 |
| Sep 30, 2018 | 99,831.00 |
| Jun 30, 2018 | 172,955.00 |
| Jun 30, 2018 | 172,955.00 |
| Mar 31, 2018 | 246,079.00 |
| Mar 31, 2018 | 246,079.00 |
| Dec 31, 2017 | 319,203.00 |
| Dec 31, 2017 | 319,203.00 |